Publication | Closed Access

The Phosphodiesterase Type IV Inhibitor Cilomilast Decreases Pro-inflammatory Cytokine Production From Primary Bronchial Epithelial Cells in Lung Transplantation Patients

AsthmaInflammationAllergyInflammatory Lung DiseaseLung InflammationMedicineImmunologyPulmonary PharmacologyImmunosuppressionLung TransplantationLung Transplantation PatientsPulmonary Disease